A study of nearly 100,000 Americans identified thousands of new variants in a set of genes that influence our responses to prescription drugs, thanks to the inclusion of participants from a more diverse set of ancestries than previous studies of these so-called pharmacogenes.
Using data from the National Institute of Health’s All of Us program, the researchers found that every participant carried at least one variant in the 16 pharmacogenes they studied, and that one in four participants had taken a medication that could be affected by these variants.
